Macular Degeneration Trial, Recruiting NCT04762368 Sponsor: University of Waterloo Condition: Macular Degeneration
Back to Macular Degeneration

Macular Degeneration Trial, Recruiting

NCT04762368
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with age-related macular degeneration (a condition affecting central vision) and are aged 60 or older, or people who have been diagnosed with juvenile macular degeneration and are currently aged 18 or older.
  • People whose vision in their better eye falls within a specific range — not too strong and not too weak — roughly between mild and moderate vision loss (confirm with trial site for exact measurements).
  • People whose reading vision in their better eye meets a minimum standard when tested at 40 cm distance (confirm with trial site for exact measurements).
  • People whose vision has been stable for the past 3 months, based on their own report.
  • People who have loss of central vision.

Who may not be able to join:

  • People who have been diagnosed with dementia.
  • People who are not able to read fluently in English (for the Waterloo site) or Chinese characters (for the Hong Kong site).
  • People who have had eye surgery or injections into the eye during the study period, unless: the injections have been ongoing continuously for at least 1 year; or the injections stopped at least 2 months before joining; or the injections were only in the eye that is not being tested.
  • People who have another eye condition — beyond macular degeneration — that could significantly reduce central vision (for example, a more advanced cataract may be a concern, while a mild cataract may be acceptable).
  • People with severe hearing impairment.
  • People who have medical reasons that would make brain stimulation unsafe for them (confirm with trial site for details).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ben Thompson, PhD, University of Waterloo

Phone: 15198884567

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Waterloo
Registry
ClinicalTrials.gov
Start date
13 February 2021
Est. completion
1 December 2026

Where this trial is recruiting

🇨🇦 Canada Hong Kong

Primary endpoints

Change in Rapid Serial Visual Presentation (RSVP) Reading performance before and right after training.; Change in Rapid Serial Visual Presentation (RSVP) Reading performance 30 days after training

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov